An outbreak of Shiga bacillus dysentery in KwaZulu/Natal, South Africa

Journal of Infection

Volumn 34, Issue 2, 1997, Pages 107-111

  Pillay, D G ^a   Karas, A J ^a   Sturm, A W ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; DYSENTERY; FEMALE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; SHIGELLA DYSENTERIAE; SHIGELLOSIS; SOUTH AFRICA;

EID: 0030889348     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)92376-8     Document Type: Article

References (21)

1. Du Pont HL. Shigella species (bacillary dysentery). In: Mandell GL, Douglas RG, Bennet JE, eds. Principles and practice of infectious diseases, 3rd ed. New York: Churchill Livingstone. 1990: 1716-1722.
2. Donald PR, Pretorius ML, Burger PJ. Shigellosis in the southwestern Cape of Good Hope 1968-85. Epidem Infect 1987; 98: 165-170.
3. Hallett AF, Scragg JN. Shigella bacteraemia in Africans. Trans R Soc Trop Med Hyg 1978; 72: 673-674.
4. Scragg JN, Rubidge CJ, Appelbaum PC. Shigella infection in African and Indian children with special reference to shigella septicaemia. J Paediatr 1978; 93: 796-797.
5. Gangarosa EJ. Perera DR, Mata LJ et al. Epidemic Shiga bacillus dysentery in Central America II. Epidemiologic studies in 1969. J Infect Dis 1970; 122: 181-190.
6. Mata JL. Gangarosa EJ, Caceres A et al. Epidemic Shiga bacillus dysentery in Central America. I. Etiologic investigations in Guatemala, 1969. J Infect Dis 1970; 122: 170-180.
7. Frost JA, Rowe B, Vandepitte J. Acquisition of trimethoprim resistance in epidemic strain of Shigella dysenteriae type 1 from Zaire. Lancet 1982; i: 963.
8. Ries AA, Wells JG, Olivola D et al Epidemic Shigella dysenteriae type 1 in Burundi: Panresistance and implications for prevention. J Infect Dis 1994; 169: 1035-1041.
9. Bloom PD, MacPhail AP, Klugman K, Louw M, Raubenheimer C, Fischer C. Haemolytic-uraemic syndrome in adults with resistant Shigella dysenteriae type 1. Lancet 1994; 344: 206.
10. Rowe B, Gross RJ. Shigella. In: Krieg NR, Holt G. eds. Bergey's manual of systematic bacteriology. Baltimore: Williams and Wilkins, 1984: 423-427.
11. Cowan ST, ed. Cowan and Steel's manual for the identification of medical bacteria. Great Britain: Cambridge University Press; 1965: 171.
12. Parker MT. Bacillary dysentery. In: Parker MT, Collier LH, eds. Principles of bacteriology, virology and immunity, 8th ed. Philadelphia: BC Decker Inc, 1990: 447-459.
13. Bennish ML, Wojtypniak BJ. Mortality due to Shigellosis community and hospital data. Rev Infect Dis 1991; 13 (Suppl. 4): 245-251.
14. Heubner J, Czerwenka W, Gruner E, von Graevenitz A. Shigellemia in AIDS patients: case report and review of the literature. Infection 1993; 21: 122-124.
15. Kustner HGV, ed. AIDS in South Africa. In: Epidemiological comments. Department of Health, South Africa, 1995; 22: 218.
16. Bennish ML. Salem MA. Rethinking options for the treatment of Shigellosis. J Antimicrob Chemother 1992; 30: 243-247.
17. Weissman J, Gangarosa E, DuPont H et al. Changing needs in the antimicrobial therapy of shigellosis. J Infect Dis 1973; 127: 611.
18. Mistra AK, Kabir I. Hossain MA. Pivmecillinam-resistant Shigella dysenteriae type 1 infection in Bangladesh. Lancet 1990; 335: 1461-1462.
19. DuPont H, Hornick R. Adverse effects of Lomitil in shigellosis. JAMA 1973; 226: 1525.
20. O'Brien AD, LaVeck GD. Thompson MR, Formal SB. Production of Shigella dysenteriae type 1 like cytotoxin by E. coli. J Infect Dis 1982; 146: 763-769.
21. Day NP. Scotland SM, Rowe B. Comparison of an Hep-2 tissue culture test with sereny test for detection of enteroinvasiveness in Shigella spp. and Escherichia coli. J Clin Microbiol 1981; 13: 596-597.